MWO:PA:PA-Amundi FTSE EPRA/NAREIT Global Developed UCITS ETF D (EUR)

ETF | Others |

Last Closing

USD 42.065

Change

-0.16 (-0.37)%

Market Cap

USD 0.10B

Volume

891.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

This fund is to track the upward and the downward evolution of the FTSE EPRA/NAREIT Develop NTR index

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.18 (+0.38%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.40 (+0.25%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.18 (+0.29%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.06 (+0.16%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.10 (-0.42%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.60 (-0.52%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.00 (+0.28%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.14 (+0.24%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.43%)

USD 5.25B

ETFs Containing MWO:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.42% 55% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.42% 55% F 54% F
Trailing 12 Months  
Capital Gain 9.38% 44% F 60% D-
Dividend Return 3.93% 82% B 67% D+
Total Return 13.31% 52% F 64% D
Trailing 5 Years  
Capital Gain -7.04% 15% F 36% F
Dividend Return 14.85% 65% D 53% F
Total Return 7.81% 25% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 3.56% 30% F 44% F
Dividend Return 6.33% 69% C- 73% C
Total Return 2.77% 93% A 64% D
Risk Return Profile  
Volatility (Standard Deviation) 16.91% 63% D 77% C+
Risk Adjusted Return 37.42% 62% D 73% C
Market Capitalization 0.10B 28% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.